Statistics

Total Visits

Views
A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study51

Select a period of time:

Number of views in the range

Views
A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study28

Views

Views
January 20251
February 20252
March 202514
April 20253
May 20254
June 20254
July 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore14
United States6
Brazil3
Hong Kong2
Spain1
United Kingdom1
Mexico1
 

Top cities views

Views
Hong Kong2
Brasília1
Canoas1
Charlotte1
Council Bluffs1
Dahlonega1
Manassas1
Morelia1
São Paulo1